Clin2
NCT07499583Possibly a fitNot yet recruiting

Psilocybin therapy for depression and substance use

Treatment Resistant DepressionSubstance Use Disorders

Treatments studied

Part of Mental health clinical trials.

This study tests whether a medicine called psilocybin, combined with talk therapy, can help people with hard-to-treat depression and a substance use problem. It aims to see if this treatment can improve mood and reduce substance use.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
50 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a veteran or first responder
  • You are between 18 and 70 years old
  • You have depression that hasn't improved after trying at least 2 different antidepressant treatments
  • You have a moderate to severe problem with alcohol, cocaine, opioids, or cannabis
  • You are generally healthy and can have an MRI scan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07183748Recruiting· Phase 2
Psilocybin microdosing plus therapy for hard-to-treat depression

This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.

Beersheba
NCT06378229Recruiting· Phase 2
Psilocybin for hospitalized treatment-resistant depression

This trial tests whether a single dose of psilocybin can help hospitalized patients with tough-to-treat depression. It focuses on people who haven't improved with standard antidepressants and need a new option.

Ghent, Oost-Vlaanderen
NCT06512220Recruiting· Phase 2
Psilocybin for treatment-resistant depression brain imaging study

This study tests whether a psilocybin-based treatment can help people with depression that has not improved after trying several antidepressants. You will receive the study treatment and have brain scans to see how it affects brain connections.

Toronto, Ontario
NCT06132178Recruiting· Phase 2
Psilocybin and rTMS for hard-to-treat depression

This study tests whether a combination of psilocybin (a psychedelic substance) and transcranial magnetic stimulation (rTMS, a noninvasive brain stimulation) can help people with treatment-resistant depression. It involves daily visits to the research center for about 2 weeks.

Austin, Texas
NCT07226232Recruiting· Phase 3
Psilocybin for veterans with treatment-resistant depression

This study tests whether psilocybin (a psychedelic substance) can help veterans with depression that hasn't improved with standard treatments.

Birmingham, Alabama
NCT07281352Recruiting· Phase 1/Phase 2
Psilocybin therapy for depression

This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.

Los Angeles, California

Hear when a new Treatment Resistant Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.